#United States #San Diego #Novo Nordisk #Virtual Care #9amHealth

9amHealth and Novo Nordisk: A New Era of Virtual Obesity Care

In an innovative partnership aimed at transforming healthcare accessibility, 9amHealth, a virtual care provider dedicated to cardiometabolic health, has joined forces with Novo Nordisk. This collaboration will enable patients nationwide to access expert-led virtual obesity care via the NovoCare website. This announcement has sparked enthusiasm as it signifies a commitment to enhancing patient support in managing chronic conditions like obesity.

An Innovative Shift in Healthcare Delivery

As the landscape of healthcare dramatically shifts, fueled by advancements in obesity medications, there is a growing demand for effective medical care.

Paul Geevarghese, Co-Founder and Chief Operating Officer at 9amHealth, emphasized the significance of this partnership, stating, “We are currently experiencing a monumental transition, driven by groundbreaking obesity medications. Individuals with cardiometabolic conditions are increasingly proactive about seeking medical assistance, which creates a unique opportunity for delivering diagnostics, preventative measures, lifestyle support, and treatment through a streamlined virtual experience.”

This collaboration not only underscores the growing need for accessible healthcare but also reflects both companies' dedication to providing high-quality care. By leveraging 9amHealth's independent specialist-led virtual clinic, patients across the U.S. now have more options for managing their obesity treatment in a safe and effective manner.

Commitment to Patient Safety and Quality Care

A cornerstone of the partnership is the adherence to evidence-based medicine. 9amHealth's model prioritizes patient safety through comprehensive medical evaluations and lab testing, steering clear of compounded products lacking FDA oversight. Dave Moore, Executive Vice President of US Operations at Novo Nordisk, reiterated the importance of equitable healthcare access, stating, “Every patient deserves timely access to expert-led care for chronic conditions like obesity, regardless of their location.”

The goal of this collaboration is clear: provide patients preferring telehealth solutions with access to validated clinical care while minimizing risks associated with unproven treatments. Moore added, “This partnership underscores our ongoing commitment to collaborating with trusted providers who uphold the highest standards of quality, safety, and clinical integrity.”

Enhanced Access to High-Quality Virtual Care

Thanks to NovoCare, patients can now connect with 9amHealth's multidisciplinary clinical team without leaving their homes. The services provided include:

• - Medical evaluation by licensed providers
• - At-home lab testing
• - Prescription of FDA-approved medications, where appropriate
• - Personalized nutrition counseling grounded in the ‘food as medicine’ philosophy
• - Continued support from a team of physicians, endocrinologists, obesity specialists, dietitians, and pharmacists

This fully virtual model ensures high-quality care while maintaining rigorous oversight, allowing patients to receive comprehensive obesity treatment tailored to their individual needs.

Affordable Comprehensive Care

The announcement arrives alongside Novo Nordisk’s recent launch of a self-pay option, making authentic, FDA-approved Wegovy available to eligible patients at a flat rate of $499 per month. This transparent price structure aims to improve affordability and discourage patients from turning to unregulated alternative treatments.

9amHealth is at the forefront of providing holistic cardiometabolic care, focusing on the prevention and treatment of obesity, diabetes, high cholesterol, and hypertension. Their innovative approach partners with employers, health plans, and pharmacy benefit managers (PBMs) to deliver effective health benefits to individuals grappling with chronic illnesses. Members benefit from personalized care plans, prescription deliveries, at-home lab testing, and unlimited access to specialists—further emphasizing their commitment to patient-centered care.

Conclusion

The partnership between 9amHealth and Novo Nordisk marks a significant development in the realm of healthcare delivery, especially for individuals struggling with obesity. By integrating high-quality virtual care with leading-edge medical expertise, this collaboration aims to redefine how patients access essential health services, ultimately paving the way for improved health outcomes across the nation. As telehealth continues to evolve, partnerships like these play a critical role in shaping the future of healthcare.